Alberto Pérez‐Mediavilla

Phenylbutyrate Ameliorates Cognitive Deficit and Reduces Tau Pathology in an Alzheimer's Disease Mouse Model

Ana Ricobaraza, Mar Cuadrado‐Tejedor, Alberto Pérez‐Mediavilla et al. · Neuropsychopharmacology · 2009 · 409 citations · Full text

Alzheimer's Disease, Aging, Dementia +10

Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology

Luís Escribano, Ana‐María Simón, Esther Gimeno et al. · Neuropsychopharmacology · 2010 · 233 citations · Full text

Alzheimer's Disease, Tau Pathology, Dementia +8

Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice

Elena M. Ribé, Mar Pérez, Berta Puig et al. · Neurobiology of Disease · 2005 · 160 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Transgenic Mouse Models +11

Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer’s disease mouse model

Luís Escribano, Ana‐María Simón, Alberto Pérez‐Mediavilla et al. · Biochemical and Biophysical Research Communications · 2008 · 138 citations

Memory Decline, Neurodegenerative Diseases, Alzheimer's Disease +11

Enhanced Expression of the Voltage-Dependent Anion Channel 1 (VDAC1) in Alzheimer's Disease Transgenic Mice: An Insight into the Pathogenic Effects of Amyloid-β

Mar Cuadrado‐Tejedor, Marcos Vilariño, Felipe Cabodevilla et al. · Journal of Alzheimer s Disease · 2011 · 136 citations · Full text

Synaptic Transmission, Neurochemical Biomarkers, Vdac1 Expression +27